SEC Filing Summary: Form 13F Information Table
Business Context and Reporting Period
This filing is a Form 13F Information Table submitted by AXON ENTERPRISE, INC. The reporting period covered is June 30, 2026. This form discloses the investment holdings of institutional investment managers as required by the Securities and Exchange Commission.
Key Financial Metrics and Holdings
The filing does not contain financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity for Axon Enterprise, Inc. Instead, it details a specific equity position held by the manager:
- Issuer: CELLEBRITE DI LTD
- Security Class: Ordinary Shares
- CUSIP: M2197Q107
- Value: $19,126,190
- Shares Held: 1,310,013
- Voting Authority: Sole (1,310,013 shares); Shared and None are 0.
Material Changes
The filing text does not provide comparative data from a prior period; therefore, material changes in holdings or value cannot be determined from this document alone.
Guidance, Outlook, and Risks
As a Form 13F, this document does not contain management commentary, forward-looking guidance, risk factors, or contingencies regarding the issuer's operations. It strictly reports the portfolio composition at the end of the reporting period.
Investor Verification Checklist
- Verify the accuracy of the share count (1,310,013) and valuation ($19,126,190) for Cellebrite DI Ltd against market data as of June 30, 2026.
- Confirm whether this represents a new position or a change in existing holdings by comparing with Axon Enterprise's prior 13F filings.
- Note that this filing reflects the holdings of Axon Enterprise as an investment manager, not the operating financial results of Axon Enterprise itself.